SB623's European ATMP designation and global expansion
A theme involving SB623 receiving advanced therapy medicinal product (ATMP) designation from the European Medicines Agency (EMA), representing regulatory progress toward global expansion, including Europe.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.